Form 4: Teladoc Health Executive Kornwasser Reports Stock Transactions

Laizer Kornwasser, President of Enterprise Growth at Teladoc Health, reports the acquisition and disposal of Teladoc Health common stock and derivative securities.

Summary

• Laizer Kornwasser, President, Enterprise Growth at Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
• On March 1, 2024, Kornwasser acquired 9,508 and 27,901 shares of common stock through the conversion of performance stock units and restricted stock units, respectively.
• Also on March 1, 2024, Kornwasser was granted 28,527 performance stock units.
• On March 4, 2024, Kornwasser disposed of 18,349 shares of common stock at a price of $14.516 per share to cover tax withholding obligations.
• Following these transactions, Kornwasser directly owns 76,283 shares of Teladoc Health common stock.
• Kornwasser also holds 19,019 performance stock units and 55,804 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report of stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The performance stock units vest as to one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common in publicly traded companies. It provides transparency into the executive's holdings and transactions in the company's stock.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership by a company executive.
• The sale of shares to cover tax obligations is a standard practice and is unlikely to significantly affect stakeholders.

Key Dates